Multi-omics bulk studies in human prefrontal cortex and multiple ALS mouse models (C9ORF72, SOD1, TDP-43, FUS) further reinforced ECM disruption as a unifying signature of disease heterogeneity. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.